Non-inteRvEntional study to observe rAtionaLe to select add-on TherapY for type 2 diabetes inadequately controlled with metformin.

Trial Identifier:	D1843R00243
Sponsor:	AstraZeneca
NCTID::	NCT02355145
Start Date:	April 2015
Primary Completion Date:	July 2016
Condition:	Diabetes: Type 2

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Bulgaria	Pleven, Bulgaria
Bulgaria	Sofia, Bulgaria
Bulgaria	Stara Zagora, Bulgaria

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.